Opportunity Information: Apply for CDC RFA GH15 1507
Apply for CDC RFA GH15 1507
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Achieving and Sustaining TB/HIV Collaborative Activities in Cambodia under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Sep 22, 2014 and posted on Sep 22, 2014.
- Applicants must submit their applications by Nov 19, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The National Tuberculosis and Leprosy Program (CENAT), housed in Cambodias Ministry of Health, is legally responsible for managing and overseeing tuberculosis prevention and treatment throughout the Kingdom of Cambodia. CENAT has been the lead for HIV/AIDS care and treatment for patients with TB co infection since it was established. It is the sole official government source in Cambodia for providing these public health services. There is no other entity within the Kingdom of Cambodia with the sole legal mandate from the Royal Government of Cambodia to manage tuberculosis prevention and treatment, including developing health policy guidelines and overseeing the provision of comprehensive health services for tuberculosis control. CENAT possesses not only the mandate but also the leadership capacity to manage these funds efficiently and in accordance with PEPFAR guidance and USG regulations. Therefore, as part of Cambodias effort to build capacity and sustainability and later resultant indigenous capacity in local organizations by providing HIV/AIDS care and treatment for patients with TB co infection, it is imperative funding be available to the National Tuberculosis and Leprosy Program (CENAT) housed in Cambodias Ministry of Health.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) funding opportunity titled "Achieving and Sustaining TB/HIV Collaborative Activities in Cambodia under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" is a discretionary cooperative agreement intended to support Cambodia in strengthening and expanding integrated tuberculosis (TB) and HIV services nationwide. Building on a long-running CDC Cambodia partnership with the National Center for Tuberculosis and Leprosy Control (CENAT) that began in 2009, the announcement describes continued support for diagnosing TB among people living with HIV, improving early detection of multidrug-resistant TB, and ensuring that TB/HIV co-infected patients are identified and treated quickly and correctly. The overall purpose is not simply short-term service delivery, but sustained national-scale implementation with stronger systems for oversight, quality improvement, and long-term program ownership within Cambodia's public health infrastructure.
A central focus of the work is scaling up and sustaining the "Three Is" package for TB/HIV collaborative activities. These include intensified case finding (ICF), which aims to systematically screen people living with HIV for TB symptoms and disease so cases are detected earlier; isoniazid preventive therapy (IPT), which helps prevent TB disease in eligible patients who do not have active TB; and infection control, which reduces the risk of TB transmission in healthcare and congregate settings through administrative, environmental, and personal protective measures. The opportunity also emphasizes rapid initiation of appropriate treatment for patients with TB/HIV co-infection, including timely start of both antiretroviral therapy and anti-tuberculosis regimens, reflecting the public health priority of reducing illness and death while limiting onward transmission.
The cooperative agreement is designed to position the national TB control program to lead implementation, monitoring, supervision, and coordination of TB/HIV activities across the country. This is explicitly described as being done in coordination with the National Center for HIV/AIDS, Dermatology, and STDs (NCHADS), reflecting the shared responsibilities needed for effective TB/HIV integration. A major sustainability component is the strengthening of monitoring and evaluation systems so the program can reliably track performance, coverage, and outcomes, and use data to guide improvements. Another capacity-building element is improving the ability of national healthcare staff to correctly diagnose and treat TB using evidence-based and cost-effective diagnostic algorithms, which implies standardizing clinical practice, improving decision-making in routine settings, and supporting consistent application of national guidelines.
In terms of applicant eligibility, the announcement is effectively limited to CENAT, housed within Cambodia's Ministry of Health. The justification is that CENAT is the sole official government entity with the legal mandate to manage and oversee TB prevention and treatment nationwide, including policy development and oversight of comprehensive TB control services. The notice also states that CENAT has historically led TB/HIV care and treatment for co-infected patients and has the leadership capacity to manage US government funds in alignment with PEPFAR guidance and US government regulations. This framing ties the award to Cambodia's longer-term goals of building indigenous capacity and ensuring that TB/HIV collaborative activities are sustained through national institutions rather than dependent on external implementers.
Administratively, the opportunity was posted on September 22, 2014, with an original and current closing date of November 19, 2014, and an archive date of December 19, 2014. It is listed under CFDA 93.067 (Global AIDS) and uses the cooperative agreement mechanism, which typically indicates substantial involvement by CDC in partnership with the recipient in areas such as technical guidance, performance monitoring, and program improvement. The listed award ceiling is $300,000, with no stated cost sharing or matching requirement. The source data also lists "ExpectedAwards: 0" and "EstimatedTotalFunding: 0," which can occur in archived listings or records where totals are not populated, but the ceiling provides a sense of the maximum anticipated funding level under the announcement. For access or technical issues related to the full announcement, the contact point is the CDC Procurement and Grants Office Technical Information Management Section (pgotim@cdc.gov, 770-488-2700).
Frequently Asked Questions (FAQs)
What is the title of this CDC funding opportunity?
The opportunity is titled "Achieving and Sustaining TB/HIV Collaborative Activities in Cambodia under the Presidents Emergency Plan for AIDS Relief (PEPFAR)."
Which agency is offering this grant opportunity?
The opportunity is offered by the Centers for Disease Control and Prevention (CDC).
What funding mechanism is being used?
This opportunity uses a discretionary cooperative agreement mechanism.
What does a cooperative agreement imply for how the project will be carried out?
A cooperative agreement typically indicates substantial involvement by CDC in partnership with the recipient. Based on the information provided, this can include technical guidance, performance monitoring, and support for program improvement.
What is the overall purpose of the award?
The purpose is to support Cambodia in strengthening and expanding integrated tuberculosis (TB) and HIV services nationwide, with an emphasis on sustained national-scale implementation and stronger systems for oversight, quality improvement, and long-term program ownership within Cambodia's public health infrastructure.
Is this opportunity focused on short-term service delivery or long-term sustainability?
The opportunity emphasizes sustained national-scale implementation rather than short-term service delivery. It highlights stronger oversight, quality improvement, and long-term ownership by Cambodia's public health institutions.
Which country is the program intended to support?
The program is intended to support Cambodia.
Which Cambodian institutions are central to this opportunity?
The National Center for Tuberculosis and Leprosy Control (CENAT) is central to the opportunity, and coordination is explicitly described with the National Center for HIV/AIDS, Dermatology, and STDs (NCHADS).
What is the history behind CDC's partnership mentioned in the announcement?
The announcement builds on a long-running CDC Cambodia partnership with CENAT that began in 2009.
What are the main technical focus areas described?
The announcement describes continued support for diagnosing TB among people living with HIV, improving early detection of multidrug-resistant TB, and ensuring TB/HIV co-infected patients are identified and treated quickly and correctly.
What are the "Three Is" for TB/HIV collaborative activities?
The "Three Is" package includes intensified case finding (ICF), isoniazid preventive therapy (IPT), and infection control.
What is intensified case finding (ICF) in this context?
ICF aims to systematically screen people living with HIV for TB symptoms and disease so TB cases are detected earlier.
What is isoniazid preventive therapy (IPT) as described here?
IPT helps prevent TB disease in eligible patients who do not have active TB.
What does "infection control" refer to in the "Three Is" package?
Infection control refers to reducing the risk of TB transmission in healthcare and congregate settings through administrative, environmental, and personal protective measures.
How does the opportunity address treatment for TB/HIV co-infected patients?
The opportunity emphasizes rapid initiation of appropriate treatment for patients with TB/HIV co-infection, including timely start of both antiretroviral therapy and anti-tuberculosis regimens.
What is the intended role of the national TB control program under this award?
The cooperative agreement is designed to position the national TB control program to lead implementation, monitoring, supervision, and coordination of TB/HIV activities across Cambodia.
Why is coordination with NCHADS highlighted?
Coordination with NCHADS is highlighted to reflect the shared responsibilities required for effective TB/HIV integration.
What monitoring and evaluation (M&E) expectations are mentioned?
A major component is strengthening monitoring and evaluation systems so the program can reliably track performance, coverage, and outcomes, and use data to guide improvements.
What capacity-building elements are included in the announcement?
The opportunity includes improving the ability of national healthcare staff to correctly diagnose and treat TB using evidence-based and cost-effective diagnostic algorithms, implying more standardized clinical practice and consistent application of national guidelines.
Who is eligible to apply for this funding opportunity?
Applicant eligibility is effectively limited to CENAT, housed within Cambodia's Ministry of Health.
Why is eligibility limited to CENAT?
The announcement states that CENAT is the sole official government entity with the legal mandate to manage and oversee TB prevention and treatment nationwide, including policy development and oversight of comprehensive TB control services. It also notes CENAT's historic leadership of TB/HIV care for co-infected patients and its capacity to manage US government funds in alignment with PEPFAR guidance and US government regulations.
How does this opportunity relate to PEPFAR?
The opportunity is explicitly under the Presidents Emergency Plan for AIDS Relief (PEPFAR) and is framed around strengthening integrated TB/HIV services and sustaining collaborative activities through national institutions.
What is the CFDA number associated with this opportunity?
The opportunity is listed under CFDA 93.067 (Global AIDS).
What is the award ceiling?
The listed award ceiling is $300,000.
Is cost sharing or matching required?
No cost sharing or matching requirement is stated.
What are the posted, closing, and archive dates for this opportunity?
The opportunity was posted on September 22, 2014. The original and current closing date is November 19, 2014. The archive date is December 19, 2014.
What does it mean that the opportunity is archived?
The listing includes an archive date (December 19, 2014), indicating it is an older, archived record rather than an active/open listing.
Why might the listing show "ExpectedAwards: 0" and "EstimatedTotalFunding: 0"?
The source data lists "ExpectedAwards: 0" and "EstimatedTotalFunding: 0," which can occur in archived listings or in records where totals are not populated. The award ceiling still indicates the maximum anticipated funding level under the announcement.
Who should be contacted for access or technical issues with the full announcement?
For access or technical issues, the contact is the CDC Procurement and Grants Office Technical Information Management Section at pgotim@cdc.gov or 770-488-2700.
Browse more opportunities from the same category: Health
Next opportunity: Funding Opportunity Announcement (FOA) DE FOA 0001162, entitled Targeted Algal Biofuels and Bioproducts (TABB)
Previous opportunity: Supporting Implementation of Sustainable Blood Safety Activities in the Republic of Kenya under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1507
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1507) also looked into and applied for these:
| Funding Opportunity |
|---|
| Increasing Capacity of the Dominican Republic Ministry of Health in the Areas of Blood Safety, Monitoring and Evaluation, Epidemiology, and Health Information Systems under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1518 Funding Number: CDC RFA GH15 1518 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,631,500 |
| Supporting Implementation of the National HIV and AIDS Strategic Plan (NSP) through Improving Coverage and Quality of HIV and AIDS Services and Strengthening Health Systems in Malawi under the President Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1553 Funding Number: CDC RFA GH15 1553 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,000,000 |
| Support the Mandate of the Ministry of Health and Social Welfare in the United Republic of Tanzania to Improve the Quality, Responsiveness, Accessibility and Sustainability of the National Health Laboratory Services (NHLS) under the Presidents Emerge Apply for CDC RFA GH15 1587 Funding Number: CDC RFA GH15 1587 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,040,000 |
| Establishment of a Strategic Partnership to Strengthen the Council of Ministries of Health of Central America (COMISCA) in the Central America Region under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1509 Funding Number: CDC RFA GH15 1509 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $418,824 |
| Service Area Competition Additional Areas (SAC AA) Baltimore, MD Gonzales, TX Los Angeles, CA and Minneapolis, MN Apply for HRSA 15 128 Funding Number: HRSA 15 128 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Nuclear Organization and Function Interdisciplinary Consortium (NOFIC)(U54) Apply for RFA RM 14 006 Funding Number: RFA RM 14 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nucleomics Tools (U01) Apply for RFA RM 14 007 Funding Number: RFA RM 14 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Study of Nuclear Bodies and Compartments (U01) Apply for RFA RM 14 008 Funding Number: RFA RM 14 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 4D Nucleome Imaging Tools (U01) Apply for RFA RM 14 009 Funding Number: RFA RM 14 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 4D Nucleome Network Organizational Hub (U01) Apply for RFA RM 14 010 Funding Number: RFA RM 14 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| 4D Nucleome Network Data Coordination and Integration Center (U01) Apply for RFA RM 14 011 Funding Number: RFA RM 14 011 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34) Apply for PAR 14 348 Funding Number: PAR 14 348 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Model Organisms Screening Center for the Undiagnosed Diseases Network (UDN) (U54) Apply for RFA RM 14 016 Funding Number: RFA RM 14 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NEI Institutional Mentored Physician Scientist Award (K12) Apply for PAR 14 352 Funding Number: PAR 14 352 Agency: National Institutes of Health Category: Health Funding Amount: $1,125,000 |
| Facile Methods and Technologies for Synthesis of Biomedically Relevant Carbohydrates (U01) Apply for RFA RM 14 015 Funding Number: RFA RM 14 015 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (R21) Apply for RFA RM 14 014 Funding Number: RFA RM 14 014 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Novel and Innovative Tools to Facilitate Identification, Tracking, Manipulation, and Analysis of Glycans and their Functions (U01) Apply for RFA RM 14 013 Funding Number: RFA RM 14 013 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Data Integration and Analysis Tools Accessible Resources for Integration and Analysis of Carbohydrate and Glycoconjugate Structural, Analytical, and Interaction Data in the Context of Comparable Gene, Protein, and Lipid Data (R34) Apply for RFA RM 14 012 Funding Number: RFA RM 14 012 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Strengthen Capacity of the Ministry of Community Development, Mother and Child Health to Support National Coordination of HIV Prevention, Care and Treatment and Related Maternal, Neonatal and Child Health Serv at District FacilityCommunity Level (PEP Apply for CDC RFA GH15 1599 Funding Number: CDC RFA GH15 1599 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,975,000 |
| Strengthening the Healthcare System of Vietnam through Capacity Building, Policy Development and Quality Improvement of Laboratory and Clinical Services under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1596 Funding Number: CDC RFA GH15 1596 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1507", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.